TrialStroke2021

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.

S Claiborne Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.